Ohri Manu 4
4 · GT Biopharma, Inc. · Filed Aug 15, 2023
Insider Transaction Report
Form 4
Ohri Manu
Chief Financial Officer
Transactions
- Award
Common Stock
2023-08-11$0.29/sh+200,000$57,400→ 200,000 total - Other
Common Stock
2023-08-11$0.29/sh+200,000$57,400→ 300,000 total(indirect: By Anarjay Concepts, Inc.) - Other
Common Stock
2023-08-11$0.29/sh−200,000$57,400→ 0 total
Holdings
- 50,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.